Clinical and Laboratory Findings in Anti-MOG Antibody Patients from Two Madrid Hospitals

Sara Muñoz-Gómez's study describes a cohort of fifteen patients diagnosed with anti-myelin oligodendrocyte glycoprotein antibodies. The data includes clinical, radiographic, and laboratory characteristics from Hospital General Universitario Gregorio Marañón and Hospital Universitario Ramón y Cajal between 2018 and 2024. Findings cover patient demographics, presentation types, antibody titers, and cerebrospinal fluid analysis results.

Use Cases

• Analyze demographic and clinical presentation patterns based on patient age, sex, and ethnicity data.
• Investigate correlations between serum/CSF antibody titers and clinical outcomes like relapse rates.
• Study the prevalence of specific laboratory findings, such as oligoclonal bands or elevated protein, in this patient cohort.

Strengths

• Cohort of fifteen patients with detailed clinical and laboratory profiles.
• Data sourced from two tertiary hospitals over a six-year period (2018-2024).
• Includes specific metrics like mean age at onset (46 years) and relapse rates (46.6%).

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset's small scale (15 patients) limits generalizability of findings.

Provenance

Source

Hospital General Universitario Gregorio Marañón and Hospital Universitario Ramón y Cajal.

Collection Method

Retrospective review of patient records.

Time Range

2018 to 2024

Freshness

Last updated 2026-05-11 04:27:50; freshness should be verified.

Geography

Madrid, Spain